Edgewise Therapeutics Inc. logo

Edgewise Therapeutics Inc.

EWTX | NASDAQ
Chart Builder DCF Calculator
$44.64
-$0.68 (-1.50%)
At close: Sep 21, 2026, 4:00 PM ET
$44.79
+$0.15 (+0.34%)
Pre-market: Sep 22, 2026, 5:31 AM ET

Market Data

Market Cap
$4.88B
Enterprise Value
$4.35B
Beta
0.28
Average Volume
1.37M
Shares Outstanding (Diluted)
107.67M
Shares Change YoY
2.6%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US28036F1057

Price Performance

Price Change 1M
1.6%
Price Change 3M
15.0%
Price Change 6M
39.8%
Price Change YTD
88.0%
Price Change 1Y
195.6%
Price Change 3Y
645.2%
Price Change 5Y
145.4%
1M CAGR (ann.)
2.0%
1Y CAGR (ann.)
226.3%
5Y CAGR (ann.)
23.0%
All-Time CAGR
7.8%

Valuation

PE Ratio
-24.13
Forward PE
N/A
PEG Ratio
1.40
Forward PEG
1.21
PS Ratio
N/A
Forward PS
124.30
PB Ratio
10.72
P/FCF Ratio
-30.09
P/Adj. FCF Ratio
-29.85
P/OCF Ratio
-30.16
EV/Sales
N/A
EV/EBIT
-22.04
EV/EBITDA
-22.04
EV/FCF
-27.23
Earnings Yield
-4.1%
FCF Yield
-3.3%
Adj. FCF Yield
-3.4%

Financial Health

Net Cash
$460.71M
Total Debt
$3.59M
Cash & Short-Term Investments
$460.71M
Total Assets
$479.69M
Current Ratio
16.24
Quick Ratio
16.24
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.02
Debt / FCF
-0.02
OCF / Debt
-44.41
Interest Coverage
0.00
Altman Z-Score
90.40
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-0.8%

Returns

Return on Assets
-41.1%
Return on Equity
-39.0%
Return on Invested Capital
-48.5%
Return on Capital Employed
-48.6%
Return on Tangible Assets
-41.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-9.1%
EPS CAGR 5Y
-12.0%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-21.1%
FCF CAGR 5Y
-26.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
10.3%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.55
EPS Growth Est (next Q)
41.0%
Revenue Est (next Q)
$129.17M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$51.90
Price Target Upside
16.3%

Cash Flow

Operating Cash Flow
$-159.42M
Free Cash Flow
$-159.62M
Adj. Free Cash Flow
$-160.9M
FCF Per Share
-$1.48
OCF Per Share
-$1.48
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-590K
Operating Income
$-218.9M
EBITDA
$-197.21M
Net Income
$-197.22M
EPS (Diluted)
-$1.85
Revenue / Employee
N/A
Profit / Employee
$-1.55M
Employees
127

© 2026 bestshares.com. All rights reserved.